TAVR vs. the Least Invasive Surgically Implanted Valve

Rapid-deployment surgically implanted valves are designed to make a surgeons’ job faster and easier, compared with conventional bioprostheses, which require several stitches. These valves, which shorten surgical times, could compete with transcatheter-implanted valves (transcatheter aortic valve replacement, TAVR).

TAVI vs la válvula quirúrgica menos invasiva

The German Aortic Valve Registry analyzed 16,473 patients who underwent surgical aortic valve replacement with either a current-generation rapid-release valve or current-generation TAVR between 2011 and 2017.

Results from both procedures and devices were compared after matching patients 1:1 using propensity score.

TAVR patients were older and had higher surgical risk scores than those who underwent surgery.

Patients who underwent surgical valve replacement with rapid-release valves suffered from more disabling stroke (1.7% vs. 1.1%; p = 0.03) and needed more transfusions (8.5% vs. 1.4%; p < 0.001) and dialysis (1.9% vs. 1.2%; p = 0.01). Besides that, they had lower pacemaker implantation rates than their TAVR counterparts (8.4% vs. 14.9%; p < 0.001). 

In-hospital mortality was similar (1.6% vs. 1.8%; p = 0.62) when analyzing raw data, but after propensity score matching, a significant advantage in favor of TAVR was found (1.7% vs. 0.6%; p = 0.003).


Read also: The Best Anticoagulant Agent for AF After TAVR.


Balloon-expandable rapid-release valves had lower residual gradients than balloon-expandable TAVR. The opposite was observed with self-expanding valves, with which rapid-release valves had higher gradients.

Conclusion

This large registry of patients with aortic stenosis showed that TAVR presents an advantage in terms of in-hospital mortality compared with surgery using rapid-release valves. Rapid-release surgically implanted valves were better than percutaneous valves only in terms of pacemaker implantation.

Hemodynamic results varied according to the release mechanism of the device.

j-jcin-2020.09.018

Título original: Transcatheter Versus Rapid-Deployment Aortic Valve Replacement. A Propensity-Matched Analysis From the German Aortic Valve Registry.

Referencia: Mohamed Abdel-Wahab et al. J Am Coll Cardiol Intv 2020;13:2642–54. https://doi.org/10.1016/j.jcin.2020.09.018.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Embolization of Left Atrial Appendage Closure Devices: Predictors, Prevention, and Management Strategies

Atrial fibrillation is associated with an increased risk of stroke and, in patients with contraindications to anticoagulation, percutaneous left atrial appendage closure represents an...

Coronary revascularization before TAVI: prior PCI or conservative management?

The coexistence of coronary artery disease (CAD) in patients with severe aortic stenosis undergoing TAVI is common, with a reported prevalence ranging from 30%...

Percutaneous Mechanical Aspiration versus Surgical Treatment of Tricuspid Valve Endocarditis

Tricuspid valve infective endocarditis (TVIE) accounts for approximately 5% to 10% of all cases of infective endocarditis. Surgical treatment remains the standard therapy in...

CRT 2026 | TAVI-CLOSE Trial: Dual Suture vs Suture + Plug for Vascular Closure After Transfemoral TAVI

The transfemoral approach is the predominant strategy for transcatheter aortic valve implantation (TAVI). Although vascular complications are currently less frequent, they remain relevant determinants...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...